Evaluation by simulation of tests based on non-linear mixed-effects models in pharmacokinetic interaction and bioequivalence cross-over trials, Statistics in Medicine, vol.83, issue.10, pp.1509-1524, 2005. ,
DOI : 10.1002/sim.2047
Cross-over trials in clinical research, 2002. ,
DOI : 10.1002/0470854596
Efficient screening of covariates in population models using Wald's approximation to the likelihood ratio test, Journal of Pharmacokinetics and Pharmacodynamics, vol.28, issue.3, pp.253-75, 2001. ,
DOI : 10.1023/A:1011579109640
Nonlinear Mixed Effects Models for Repeated Measures Data, Biometrics, vol.46, issue.3, pp.673-87, 1990. ,
DOI : 10.2307/2532087
Mixed-effect models in S and Splus, 2000. ,
Bioequivalence trials, intersection-union tests and equivalence confidence sets (with discussion), Statist Sci, vol.11, pp.283-319, 1996. ,
Interactions between Atazanavir-Ritonavir and Tenofovir in Heavily Pretreated Human Immunodeficiency Virus-Infected Patients, Antimicrobial Agents and Chemotherapy, vol.48, issue.6, pp.2091-2097, 2004. ,
DOI : 10.1128/AAC.48.6.2091-2096.2004
Oral Ganciclovir Systemic Exposure Is Enhanced in HIV-Infected Patients With Diarrhea and Weight Loss, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.24, issue.4, pp.344-51, 2000. ,
DOI : 10.1097/00126334-200008010-00008
Increased oral ganciclovir bioavailability in HIV-infected patients with chronic diarrhoea and wasting syndrome-a population pharmacokinetic study, British Journal of Clinical Pharmacology, vol.35, issue.6, pp.557-65, 2001. ,
DOI : 10.1046/j.0306-5251.2001.01389.x
Enhanced Saquinavir Exposure in Human Immunodeficiency Virus Type 1-Infected Patients with Diarrhea and/or Wasting Syndrome, Antimicrobial Agents and Chemotherapy, vol.48, issue.2, pp.538-583, 2004. ,
DOI : 10.1128/AAC.48.2.538-545.2004
Further Developments of the Fisher Information Matrix in Nonlinear Mixed Effects Models with Evaluation in Population Pharmacokinetics, Journal of Biopharmaceutical Statistics, vol.13, issue.2, pp.209-236, 2003. ,
DOI : 10.1081/BIP-100101009